Takashi Shigematsu

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

International journal of nephrology and renovascular disease

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Wakayama Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Wakayama Medical University Apr 01 2006

Japan

PHD :: Department of Nephrology

Publications

Takashi Shigematsu, Fumihiko Koiwa, Yoshitaka Isaka, Masafumi Fukagawa, Keiko Hagita, Yukihisa S Watanabe, Daisuke Honda, Tadao Akizawa
Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Randomized Placebo-Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN (2023)
Takashi Shigematsu, Shinji Asada, Yuichi Endo, Takehisa Kawata, Masafumi Fukagawa, Tadao Akizawa
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism. PloS one 17 (2) (2022)
Takashi Shigematsu, Shinji Asada, Yuichi Endo, Takehisa Kawata, Masafumi Fukagawa, Tadao Akizawa
Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis. International journal of nephrology and renovascular disease 13 (2020)
Seiji Hashimoto, Tomochika Maoka, Rie Yamamoto, Keisuke Kawashima, Akira Nishikawa, Katsumi Sakurada, Takao Koike, Takashi Shigematsu
Comparison of bioelectrical impedance analysis in healthy pregnant women and patient on hemodialysis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 25 (2) (2020)
Takashi Shigematsu, Masafumi Fukagawa, Keitaro Yokoyama, Takashi Akiba, Akifumi Fujii, Atsushi Shinoda, Tadao Akizawa
Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism. Nephrology (Carlton, Vic.) 25 (8) (2019)
Takashi Shigematsu, Ryoichi Muraoka, Toshitsugu Sugimoto, Yoshiki Nishizawa
Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials. BMC nephrology 18 (1) (2017)

Takashi Shigematsu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takashi Shigematsu